Under way, not recruiting
Analysis of Immediate Urinary Continence Predictors After RS-RARP
NCT06850116 · First Affiliated Hospital of Fujian Medical University · Updated 4 April 2025
- What is being tested
- Retzius-sparing robot-assisted radical prostatectomy
- For
- Prostate Cancer (Post Prostatectomy); Urinary Continence; Retzius-sparing Robot-assisted Radical Prostatectomy
- Kind of study
- Watches patients without assigning a treatment. No drug phase (a device or procedure study).
- Who can join
- Ages Not stated. About 400 people. The full rules are on the registry page.
- Where
- China
- When
- Starts or started 1 Jan 2025, ends 1 Jan 2027. Registered 27 Feb 2025.
- Results
- None posted yet.
In the researchers' words
This study is a retrospective, single-center clinical trial. It aims to retrospectively analyze the immediate postoperative urinary continence recovery in prostate cancer patients who underwent Retzius-sparing robot-assisted radical prostatectomy in the investigators' center. Based on the general conditions of patients, relevant perioperative clinical indicators, and parameters related to the sphincter and prostate gland measured by MRI, it explores the influencing factors of immediate urinary continence recovery after Retzius-sparing robot-assisted radical prostatectomy in prostate cancer patients and constructs a relevant prediction model, thereby providing clinical guidance value for predicting immediate postoperative urinary continence recovery.
Sites
- first hospital affiliated of Fujian medical universityFuzhou, Fujian, China